The effectiveness assessment of thrombolytic therapy in cases of complicated forms of diabetic foot
To study the effectiveness of thrombolytic therapy of necrotic complications by diabetic foot results were analyzed 32 patients. On a background of basic therapy was administered intravenously Urokinase Medak at a dose of 100 000 units within 5 - 7 days (study group). The control group were 30 patients who received a basic therapy. The effective influence of urokinase on the pathogenetic bases of diabetic foot (hemostasis, endogenous intoxication, regional blood circulation and microcirculation) presents a rationality of its inclusion in the scheme of treatment of diabetic foot syndrome.